A detailed history of Seven Bridge Financial Group, LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 41,000 shares of XLO stock, worth $56,170. This represents 0.01% of its overall portfolio holdings.

Number of Shares
41,000
Previous 31,000 32.26%
Holding current value
$56,170
Previous $33,000 15.15%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.9 - $1.53 $9,000 - $15,300
10,000 Added 32.26%
41,000 $38,000
Q1 2024

May 10, 2024

BUY
$0.55 - $1.08 $17,050 - $33,480
31,000 New
31,000 $33,000

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $37.6M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.